Skip to content

Predicting Colorectal Cancer - Tissue Samples to Evaluate Tumour Characteristics and Treatment Response

Predict - a Translational Study to Predict Tumour Response to Neoadjuvant Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04130971
Acronym
Predict
Enrollment
800
Registered
2019-10-18
Start date
2019-02-01
Completion date
2027-12-31
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Brief summary

All adult patients with colorectal cancer presenting within the Sahlgrenska University Hospital or treated at any time at Sahlgrenska University Hospital are eligible and will be asked to participate. We already have biopsies taken at surgery in patients that receive surgery, but this study will include all patients and the biopsies will be taken during endoscopy for diagnosis of the primary tumour. Biopsies will then be taken during follow-up exams prior surgery but after neoadjuvant treatment. Biopsies will also be taken during surgery and in cases where surgery is not necessary biopsies will be taken regularly during follow-up exams. Blood samples and in relevant cases urinary samples and mouth swabs will be taken at all timepoints when biopsies are taken. If it is not possible to take biopsies prior treatment blood samples will still be drawn.

Interventions

No intervention, just observation of the differences between groups and within patients.

Sponsors

Göteborg University
CollaboratorOTHER
Sahlgrenska University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colorectal cancer

Exclusion criteria

* Not colorectal cancer

Design outcomes

Primary

MeasureTime frameDescription
Tumour response to treatment1-2 months after initiated treatmentTumour microenviroment changes

Secondary

MeasureTime frameDescription
Normal tissue response to treatment1month -3 years after treatmentExtra cellular matrix changes

Countries

Sweden

Contacts

Primary ContactEva Angenete
eva.angenete@vgregion.se0760514441

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026